GlassScriptPhysician profile
Antonio Fernandez
NPI 1255383832
$17,483.24
in general payments reported to CMS, 2019-2025
60 companies · $2,899 in 2025
The $2,899 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,734 · 2020: $2,410 · 2021: $1,798 · 2022: $2,283 · 2023: $2,548 · 2024: $2,811 · 2025: $2,899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,258.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,007.41 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,671.90 | 2019-2025 | Airsupra, Farxiga, Andexxa |
| Lilly USA, LLC | $1,433.88 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,138.14 | 2019-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $919.74 | 2019-2025 | Xifaxan, Trulance |
| Amgen INC. | $914.10 | 2019-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $736.14 | 2019-2025 | |
| Allergan, INC. | $695.65 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $646.69 | 2022-2024 | |
| Kowa Pharmaceuticals America, INC. | $580.46 | 2019-2025 | Zoryve, Livalo, Seglentis |
| Boston Scientific Corporation | $576.07 | 2023-2025 | Watchman Flx |
| Abbvie INC. | $376.51 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $372.81 | 2023-2025 | Gemtesa |
| Glaxosmithkline, LLC. | $351.19 | 2019-2024 | Arexvy, Shingrix |
| Eisai INC. | $347.46 | 2020-2025 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.